Identifying tissue markers that predict early stenosis in AV fistulas for hemodialysis
Official title: Tissue Markers Predictive of Early Stenosis in the Arterovenous Fistula for Hemodialysis
Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06815159 · Data updated 2026-11-12
This study is trying to find out if certain tissue markers can help predict early narrowing in arteriovenous fistulas for people starting hemodialysis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Status | Recruiting |
| Started | March 18, 2020 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | February 7, 2025 |
| Trial ID | NCT06815159 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are undergoing their first AVF surgery or reoperation for AVF complications.
✕Probably not a fit
Patients who are not candidates for AVF surgery or those with contraindications to the procedure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study recruits two groups of patients undergoing surgery for arteriovenous fistulas (AVF) for hemodialysis. The first group consists of patients undergoing their first AVF surgery, while the second group includes patients reoperated for complications or new AVF creation. Tissue samples will be collected from both groups and analyzed for markers that may indicate early stenosis. The study aims to explore the relationship between these tissue markers and the occurrence of stenosis in AVFs.
Why it matters
Potential benefit: If successful, this study could lead to improved predictive measures for early stenosis in AV fistulas, enhancing patient outcomes in hemodialysis.
How similar studies have gone: While the approach of identifying tissue markers is common, the specific focus on early stenosis in AV fistulas is relatively novel and has not been extensively tested in previous studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than or equal to 18 years; * Patients candidates for first AVF for hemodialysis or correction of AVF complication, as part of the normal care pathway; * Obtaining informed consent signed by the patient Exclusion Criteria:
Where it's running
-
IRCCS AOU di Bologna Policlinico di Sant'Orsola
Bologna, Italy Recruiting
Study contacts
- Principal investigator: Mauro Gargiulo, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Mauro Gargiulo, MD
- Email: mauro.gargiulo2@unibo.it
- Phone: 0512143288
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for the Serranator device in treating peripheral artery disease and dialysis fistula issues
This study is collecting information on how well the Serranator device works for people with peripheral artery disease and dialysis fistula problems while they receive standard treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.